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express	HCA2	 (Q‐PCR,	 immunofluorescent	 labelling),	 siRNA‐mediated	 silencing	 of	
which	prevented	the	NA‐induced	Ca2+‐signal	and	the	lipostatic	action.	Collectively,	
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1  | INTRODUC TION
Acne	 is	 one	 of	 the	most	 common	 human	 skin	 diseases.	 It	 impairs	
quality	of	life	of	millions	of	patients	world‐wide,	and	is	characterized	
by	 excessively	 increased	 and	 qualitatively	 altered	 sebaceous	 lipo‐
genesis	(SLG),	complex	inflammatory	processes,	as	well	as	abnormal	
skin—microbiota	 cross‐talk.1‐4	 Although	 highly	 efficient	 anti‐acne	





Nicotinic	 acid	 (NA)	 and	 nicotinamide	 are	 members	 of	 the	 vi‐
tamin	 B3	 complex,	 whose	 deficiency	 leads	 to	 pellagra,	 a	 disease	
classically	characterized	by	diarrhoea,	dementia,	dermatitis,	and,	 if	
























Importantly,	 when	 applied	 at	 pharmacological	 doses,	 side	 ef‐





we	 hypothesized	 that	 NA	 may	 directly	 impact	 on	 the	 biology	 of	










bocytes	and	 the	 lack	of	 adequate	animal	model	 systems,3,21,22 we 
decided	to	use	the	human	immortalized	SZ95	sebocyte	cell	line,22,23 
a	 widely	 accepted	 and	 reliable	 model	 to	 study	 human	 sebaceous	
gland	biology	in	vitro.2,3,22,23
2  | MATERIAL S AND METHODS
2.1 | Materials
Anandamide	 (AEA)	 and	 arachidonic	 acid	 (AA)	 were	 purchased	
from	 Cayman	 Chemical	 Company	 (Ann	 Arbor,	 MI,	 USA);	 γ‐ir‐





solute	 ethanol,	 whereas	 the	 solvent	 for	 BAPTA	 AM,	 T	 and	 RR	
was	dimethyl	sulphoxide	 (DMSO).	LPS	was	dissolved	 in	 filtered	
distilled	water,	whereas	NA	was	 diluted	 directly	 in	 the	 culture	
medium.
2.2 | Cell culturing
Human	 immortalized	 SZ95	 sebocytes,	 originated	 from	 human	
facial	 sebaceous	 glands,23	 were	 cultured	 as	 described	 previ‐
ously.24,25	 Briefly,	 Sebomed®	 Basal	 Medium	 (Biochrom,	 Berlin,	
Germany)	was	supplemented	with	10	(V/V)%	fetal	bovine	serum	
(Life	 Technologies	 Hungary	 Ltd,	 Budapest,	 Hungary),	 1	 mmol/L	
CaCl2,	 5	 ng/ml	 human	 epidermal	 growth	 factor	 (Sigma‐Aldrich)	
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2.3 | Determination of intracellular lipids




Subsequently,	 supernatants	 were	 discarded,	 cells	 were	 washed	
twice	 with	 phosphate‐buffered	 saline	 (PBS;	 115	 mmol/L	 NaCl,	
20 mmol/L Na2HPO4,	pH	7.4;	all	from	Sigma‐Aldrich),	and	100	µl	of	a	
1	µg/ml	Nile	Red	(Sigma‐Aldrich)	solution	in	PBS	was	added	to	each	





















Ltd.).	24‐26	Cells	 (20	000	cells/well)	were	cultured	 in	96‐well	 “black	































of	DilC1(5)	 intensity	 indicated	mitochondrial	 depolarization	 (ie	 the	
onset	 of	 early	 apoptotic	 processes),	 whereas	 increase	 of	 SYTOX	
Green	staining	intensity	revealed	necrotic	cell	death.
2.7 | Determination of cellular proliferation
The	 degree	 of	 cellular	 growth	 (reflecting	 proliferation)	was	 deter‐
mined	by	measuring	the	DNA	content	of	cells	using	CyQUANT	Cell	
Proliferation	Assay	Kit	(Life	Technologies	Hungary	Ltd).24,26,27	SZ95	
sebocytes	 (2000	 cells/well)	 were	 cultured	 in	 96‐well	 “black	 well/









2.8 | RNA isolation, reverse transcription and 




ment	 was	 performed	 according	 to	 the	 manufacturer's	 protocol,	
and	 then,	 1	 µg	 of	 total	 RNA	 was	 reverse‐transcribed	 into	 cDNA	
using	 High‐Capacity	 cDNA	 Kit	 from	 Life	 Technologies	 Hungary	
Ltd.	 PCR	 amplification	 was	 performed	 using	 the	 TaqMan® Gene 
Expression	Assays	(assay	IDs:	Hs00174092_m1	for	interleukin [IL]‐1α,	
Hs00174097_m1	 for	 IL‐1β,	Hs00985639_m1	 for	 IL‐6,	Hs00174103_


























AM	 (Life	 Technologies	 Hungary	 Ltd.)	 dissolved	 in	 Hank's	 solution	
(100	μl/well)	 at	 37°C	 for	 30	minutes.	 The	 cells	were	 then	washed	
three	 times	 with	 Hank's	 solution	 (100	 μl/well).	 In	 the	 case	 of	 the	
measurements	performed	in	“Low	[Ca2+]EC”,	CaCl2	was	omitted	from	
the	 buffer,	 and	 was	 substituted	 by	 equimolar	 glucose.	 The	 plates	
were	then	placed	into	a	FlexStation	3	multi‐mode	microplate	reader	
(Molecular	 Devices),	 and	 alterations	 of	 the	 cytoplasmic	 Ca2+ con‐
centration	(reflected	by	changes	 in	fluorescence;	λEX:	490	nm,	λEM: 
520	 nm)	 were	 monitored	 following	 the	 application	 of	 compounds	
in	the	indicated	concentrations.	In	order	to	probe	reactivity	and	vi‐
ability	of	the	cells,	at	the	end	of	each	measurement,	0.2	mg/ml	ATP	
was	 administered	 as	 a	 positive	 control	 (data	 not	 shown).	Data	 are	
presented	as	F/F0,	where	F0	is	the	average	baseline	fluorescence	(ie	
before	compound	application),	whereas	F	is	the	actual	fluorescence.





and	 the	 cells	were	 transfected	with	 siRNA	oligonucleotides	 targeting	








Human	 SZ95	 sebocytes	were	 cultured	 on	 glass	 coverslips	 in	 6‐well	
plates.	Cells	were	fixed	by	4%	paraformaldehyde	containing	PBS	for	
5	 minutes	 at	 room	 temperature.	 Following	 appropriate	 washing	 in	
PBS,	 coverslips	were	 incubated	 for	 30	minutes	 in	 blocking	 solution	
(3	 [V/V]%	bovine	 serum	 albumin	 containing	 PBS;	 both	 from	Sigma‐
Aldrich)	at	room	temperature.	Following	appropriate	washing	in	PBS,	
cells	were	probed	with	primary	antibodies	raised	against	human	HCA2 





Signaling	 Technology,	 Leiden,	 The	 Netherlands)	 and	 DAPI	 (1:1000,	
Vector	 Laboratories,	 Burlingame,	 CA,	 USA)	 diluted	 together	 in	 1.5	
(V/V)%	BSA	containing	PBS	 for	1	hour	at	 room	 temperature,	which	
was	followed	by	appropriate	washing	in	PBS.	As	negative	controls,	the	
primary	 antibodies	 were	 omitted	 from	 the	 procedure.	 Visualization	
of	the	proteins	was	performed	by	using	an	Olympus	IX81	fluorescent	
microscope	 (Olympus,	 Sindzsuku,	 Tokyo,	 Japan).	 When	 indicated,	








Data	 were	 analysed	 by	 IBM SPSS Statics software version 20	 (IBM	
Armonk,	 North	 Castle,	 NY,	 USA),	 using	 Student's	 two‐tailed,	
two‐sample	 t	 test	 (paired	 comparisons)	 or	 one‐way	 ANOVA	 with	
Bonferroni's	post hoc	test	(multiple	comparisons),	and	P	<	0.05	val‐
ues	were	 regarded	as	significant	differences.	Graphs	were	plotted	






3.1 | Up to 100 μmol/L, NA does not decrease the 
viability of human sebocytes
First,	by	using	MTT‐assay,	we	found	that	up	to	100	µmol/L	NA	did	
not	 decrease	 the	 viability	 of	 sebocytes	 (24‐72	 hours;	 Figure	 S1).	
In	 order	 to	 exclude	 the	 possibility	 of	 the	 onset	 of	 early	 apoptotic	
and	 necrotic	 processes	 resulting	 in	 no	 obvious	 alterations	 in	 the	






S2),	 confirming	 that	 in	 this	 time	window	and	concentration	 range,	
it	 can	 indeed	 be	 administered	without	 the	 risk	 of	 any	 biologically	
relevant	cytotoxic	actions.
3.2 | NA does not influence homeostatic SLG, 
but normalizes various lipogenic agent‐induced, 
excessive, acne‐mimicking lipid synthesis
Next,	 by	 using	 fluorescent	 Nile	 Red	 staining,	 we	 aimed	 to	 study	
the	effects	of	NA	on	the	most	characteristic	biological	function	of	
the	sebocytes,	ie	the	basal,	homeostatic	SLG.	We	found	that,	when	















or	 if	 it	 rather	 reflects	 activation	of	 a	universal	 lipostatic	 signalling	
pathway,	 we	 probed	 NA’s	 efficiency	 against	 such	 stimuli,	 which	
are	 known	 to	 activate	 partially	 independent	 lipogenic	 signalling	
pathways.	 To	 this	 end,	 the	 endocannabinoid	 anandamide	 (AEA;	
30 μmol/L),33‐35	 an	 endogenous	 lipid	 mediator,	 which	 was	 shown	
to	promote	SLG	via	activating	CB2	cannabinoid	receptor,
31	and	the	
combination	 of	 linoleic	 acid	 and	 testosterone	 (LA	 +	 T	 in	 100	 and	
1 μmol/L,	respectively)	targeting	peroxisome	proliferator‐activated	
receptors	 (PPARs)36	 were	 applied.	 Of	 great	 importance,	 NA	 sup‐
pressed	both	lipogenic	stimuli,	irrespective	of	the	underlying	signal‐
ling	pathways	 (Figure	S3A‐B),	 supporting	 the	concept	 that	NA	 is	a	
universally	effective	 lipostatic	 agent	 (ie	 it	 can	normalize	excessive	
SLG	irrespective	of	the	actual	lipogenic	pathway),	which	might	even	
be	of	therapeutic	value	in	acne.
3.3 | NA exerts anti‐proliferative actions, but 
does not influence lipopolysaccharide (LPS)‐induced 
















NA	 exerted	 a	 significant	 and	 concentration‐dependent	 anti‐prolif‐
erative	 effect,	 ie	 it	 suppressed	 cell	 growth	 compared	 to	 the	 daily	
























treatments	 (to	 observe	 release	 of	 de	 novo	 synthesized	 cytokines)	
did	 not	 reveal	 any	 NA‐mediated	 effects	 on	 the	 cytokine	 release	
(Figure	2B‐C).	Thus,	our	data	support	the	concept	that	NA	is	unlikely	
to	directly	influence	immune	behaviour	of	human	sebocytes.
3.4 | Lipostatic effects of NA are mediated via the 
activation of a Ca2+‐dependent signalling pathway
Next,	we	intended	to	unveil	the	mechanism	of	the	lipid	synthe‐
sis	reducing	activity.	Since	elevation	of	the	[Ca2+]IC	often	leads	
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to	lipostatic	actions	similar	to	the	ones	described	above,26,41‐43 
and	 it	 is	 well‐documented	 that	 administration	 of	 NA	 elevates	
[Ca2+]IC	 in	 certain	 cell	 types,
10,11	 we	 first	 asked	 if	 alterations	
of	 [Ca2+]IC	 play	 any	 role	 in	mediating	 lipostatic	 effects	 of	NA.	
Importantly,	we	found	that	lipostatic	effects	could	be	prevented	
by	 the	 co‐administration	 of	 the	 cell‐permeable	 Ca2+‐chelator	
BAPTA	AM	 (Figure	3A),	 indicating	 that,	 similar	 to	 eg	CBD,	NA	
also	 suppressed	 SLG	 via	 activating	 a	 Ca2+‐coupled	 signalling	
pathway.
3.5 | Lipostatic concentrations of NA increase 
[Ca2±]IC via activating surface membrane non‐TRPV 
Ca2± channels
Next,	 we	 found	 that	 potent	 lipostatic	 and	 anti‐proliferative	 con‐
centrations	 of	 NA	 were	 able	 to	 substantially	 and	 concentra‐
tion‐dependently	 increase	 [Ca2+]IC	 (Fluo‐4	 AM‐based	 fluorescent	









we	 found	 that	 RR	was	 unable	 to	modify	 the	NA‐induced	 calcium	
signals	 (Figure	3B‐C)	 indicating	that	they	are	 likely	to	be	mediated	
via	yet	unknown,	non‐TRPV	surface	membrane	calcium	permeable	
pores.
3.6 | Sebocytes express HCA2 receptor, which 
selectively mediates lipostatic and [Ca2±]IC‐increasing 
effects of NA
Since	the	above	functional	data	on	the	calcium	homeostasis	made	
the	 involvement	 of	 TRPV	 channels	 in	mediating	 lipostatic	 actions	
of	NA	highly	unlikely,	we	asked	if	the	major	NA	receptor,	 ie	HCA2,	
contributes	to	this	process.	Importantly,	we	found	that	HCA2	is	in‐
deed	 expressed	 by	 human	 sebocytes	 both	 at	 the	mRNA	 (Q‐PCR;	
Figure	4A)	and	protein	levels	(immunofluorescence;	Figure	4B).	Next,	
in	 the	 lack	 of	 potent	 and	 selective	 antagonists,14	 siRNA‐mediated	
selective	gene	silencing	was	applied,	which	resulted	in	a	significant	
decrease	 in	both	mRNA	 (Figure	5A)	 and	protein	 (Figure	5B‐C)	 ex‐
pression	of	HCA2.	Moreover,	as	revealed	by	Nile	Red	assays	simulta‐
neously	executed	on	non‐sense	RNA‐transfected	scrambled	control	































basal,	 homeostatic	 lipid	 synthesis	 (Figure	 1A)	 or	 viability	 (Figures	
S1	and	S2)	of	human	sebocytes,	NA	normalizes	acne‐mimicking,	ex‐
cessive	SLG	induced	by	various	pro‐acne	agents	(Figure	1B;	Figure	














clinical	 trials	were	 organized	 so	 far	 to	 dissect	 the	 acne‐wise	 rele‐
vant	 dermatological	 effects	 of	 NA,	 beyond	 our	 above	 presented	




(https	://www.drugs.com/pro/niacin.html).	 Third,	 results	 of	 certain	








otinamide's	 anti‐acne	 actions	 is	 still	 only	 partially	 understood,53 
it	 is	well‐evidenced	that	it	does	not	activate	HCA2;
16,17	therefore,	
it	definitely	does	not	share	 the	above	described	 lipostatic	 signal‐
ling	pathway	of	NA.	However,	considering	that	NA	can	be	metab‐
olized	 to	nicotinamide	 in	vivo,54	 it	 can	be	postulated	 that	 clinical	
efficiency	of	topically	administered	NA	might	even	be	superior	to	
the	one	of	nicotinamide,	since	theoretically,	 it	could	 include	both	
HCA2‐dependent	 direct,	 and,	 following	 its	 conversion	 to	 nicotin‐
amide,	HCA2‐independent,	indirect	anti‐acne	effects.




chotropic	 phytocannabinoid	 (‐)‐cannabidiol,	 the	 observed	 anti‐
inflammatory	 inefficiency	 of	 NA	 is	 not	 completely	 unexpected.	
Indeed,	(‐)‐cannabidiol	was	found	to	exert	lipostatic	and	anti‐pro‐





that	 activation	 of	 another	 Ca2+‐permeable	 ion	 channel	 (namely	
TRPV3)	 suppressed	 SLG,	 and	 enhanced	 expression	 and	 release	
of	several	pro‐inflammatory	cytokines.42	Thus,	it	is	not	surprising	
that	 NA	was	 efficient	 in	 normalizing	 the	 SLG	 via	 the	HCA2‐de‐
pendent	elevation	of	 the	 [Ca2+]IC,	 but	 failed	 to	prevent	 the	pro‐
inflammatory	 action	 of	 LPS.	 Importantly,	 however,	 NA	 can	 still	
be	 effective	 in	 alleviating	 the	 acne‐accompanying	 pathological	
inflammation.55‐58
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Indeed,	as	discussed	above,	NA	appears	to	have	negligible	ef‐






















controlled	 clinical	 trials	 by	 using	 appropriate	 topical	 formulations	
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delivering	NA	directly	to	the	sebaceous	glands	and	thereby	minimizing	
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